NanoViricides, Stock

NanoViricides, EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of NanoViricides, (NNVC) as of Aug 17, 2026 is -2.34. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -2.59 — a change of -9.53% (higher).

EV/FCF

-2.34

YoY

-9.53%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of NanoViricides, is 2026 -2.34 . EV/FCF (Enterprise Value to Free Cash Flow) of NanoViricides, was 2025 -2.59 . It decreases by -9.53% higher compared to the previous year.
Access this data via the Eulerpool API

NanoViricides, Stock analysis

What does NanoViricides, do? NanoViricides Inc. is a biopharmaceutical company specializing in the development of therapeutics for the treatment of virus infections. The company's unique technology is based on nanoparticles that specifically target and destroy virus cells. The company was founded in 2005 by Farooq Ansari, a former top manager at Pfizer. Together with his team, he quickly recognized the potential of nanotechnology in combating diseases and began developing various products based on this technology. NanoViricides Inc.'s business model is based on the development and commercialization of nanoparticle-based therapeutics in the global health market. The company works closely with leading research and development institutions to expand knowledge and technology in this field. NanoViricides Inc. has several product divisions specializing in combating different virus infections. The main divisions are: - FluCide: Focuses on the development of therapeutics for the treatment of influenza infections. Flu is one of the most widespread virus infections worldwide and can lead to serious complications such as pneumonia. - HerpeCide: Focuses on the development of therapeutics for the treatment of herpesvirus infections, including genital herpes, shingles, and chickenpox. - HIVCide: Focuses on the development of therapeutics for the treatment of HIV infections, aiming to develop a safer and more effective cure for HIV. - RabiCide: Focuses on the development of therapeutics for the treatment of rabies infections. - CoronaCide: Focuses on the development of therapeutics for the treatment of coronaviruses, including SARS-CoV-2, the virus that causes COVID-19. NanoViricides Inc. has a range of products in various stages of development and research, with some already in clinical studies. The company continuously strives to improve its products and expand its research and development efforts. In summary, NanoViricides Inc. is a biopharmaceutical company specializing in the development of therapeutics for the treatment of virus infections. It utilizes a unique technology based on nanoparticles to directly combat viruses at the cellular level. With multiple product divisions and a strong team of researchers and developers, NanoViricides Inc. is continuously working to improve the health of patients worldwide. The answer is: NanoViricides Inc. is a biopharmaceutical company specializing in the development of therapeutics for virus infections using nanoparticle-based technology. NanoViricides, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NanoViricides, stock

EV/FCF (Enterprise Value to Free Cash Flow) of NanoViricides, is -2.34 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of NanoViricides, changed from -2.59 to -2.34, representing a -9.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) NanoViricides, since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s NanoViricides, with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — NanoViricides,

All Key Metrics — NanoViricides,